Skip to main content

Pain Medication News

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone)...

Ask a question

To post your own question to this support group, sign in or create an account.